Liposomal Vaccine to Streptococcus Pneumoniae Type 3 and 14

  • H. Snippe
  • A. F. M. Verheul
  • J. E. G. van Dam
Part of the NATO ASI Series book series (NSSA, volume 179)


Streptococcus pneumoniae is responsible for lower-respiratory-tract infections in humans and also the most common cause of otitis media (bacterial middle ear infection) in children. Pneumococcal pneumonia is rarely a primary infection of the lung but such factors as damage to the respiratory tract, fatigue, chilling of the body and general debilitation predispose to infection. S. pneumoniae can be isolated from the pharynx of 30–70% of apparently normal humans.


Streptococcus Pneumoniae Pneumococcal Vaccine Capsular Polysaccharide Reductive Amination Liposomal Membrane 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amsbaugh, D.F., Hansen, C.T., Prescott, B., Stashak, P.W., Barthold, D.R. and Baker, P.J., 1972, Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness, J.Exp.Med., 136: 931.PubMedCrossRefGoogle Scholar
  2. Aplin, J.D. and Wriston, J.C., 1981, Preparation, properties, and applications of carbohydrate conjugates of proteins and lipids, C.R.C. Crit.Rev.Biochem., 5: 295.Google Scholar
  3. Austrian, R., 1981, Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention, Rev.Infect.Dis., 3: S1.PubMedCrossRefGoogle Scholar
  4. Baker, P.J., Stashak, P.W. and Prescott, B., 1969, Use of erythrocytes sensitized with purified pneumococcal polysaccharide for the assay of antibody and antibody-producing cells, Appl.Microbiol., 17: 422.PubMedGoogle Scholar
  5. Björk, I., Larm, O., Lindberg, U., Norling, K. and Riquelme, M-E., 1982, Permanent activation of antithrombin by covalent attachment of heparin oligosaccharides, FEBS Lett., 143: 96.PubMedCrossRefGoogle Scholar
  6. Campbell, J.H. and Pappenheimer, A.M., 1966, Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies types III and VIII. I. Isolation of oligosaccharides from acid and from enzymic hydrolysates, Immunochemistry, 3: 195.PubMedCrossRefGoogle Scholar
  7. Chernyak, A.Y., Antonov, K.V., Kochetkov, N.K., Padyukov, L.N. and Tsvetkova N.V., 1985, Two synthetic antigens related to Streptococcus pneumoniae type 3 capsular polysaccharide, Carbohydr.Res., 141: 199.PubMedCrossRefGoogle Scholar
  8. Defaye, J., 1970, 2,5-Anhydrides of sugars and related compounds, Adv. Carbohydr.Chem.Biochem., 25: 181.CrossRefGoogle Scholar
  9. Erbing, C., Lindberg, B. and Svensson, S., 1979, Deamination of methyl 2-amino-2-deoxy-a-and-b-D-glucopyranosides, Acta Chem.Scand., 27: 3699.CrossRefGoogle Scholar
  10. Finland, M., 1978, And the walls come tumbling down. More antibiotic resistance, and now the pneumococcus, N.Engl.J.Med., 299: 770.PubMedCrossRefGoogle Scholar
  11. Fogler, W.E., Swartz, G.M. and Alving, C.R., 1987. Antibodies to phospholipids and liposomes: binding of antibodies to cells, Biochim. Biophys.Acta, 903: 265.PubMedCrossRefGoogle Scholar
  12. Gigg, R., 1980, Synthesis of glycolipids, Chem.Phys.Lipids, 26: 287.PubMedCrossRefGoogle Scholar
  13. Goebel, W.F., 1940, Studies on antibacterial immunity induced by artificial antigen II immunity to experimental pneumococcal infection with an antigen-containing cellobiuronic acid, J.Exp.Med., 69: 353.CrossRefGoogle Scholar
  14. Gosh, P., Bachkawat, B.K. and Surolia, A., 1981, Synthetic glycolipids: interaction with galactose-binding lectin and hepatic cells, Arch. Biochem.Biophys., 206: 454.CrossRefGoogle Scholar
  15. Health and Public Policy Committee (Am. Coll. Phys.) 1986, Pneumococcal vaccine, Ann.Int.Med., 104: 118.Google Scholar
  16. Hilgers, L.A.T., 1986, Immunomodulating properties of synthetic adjuvants, Thesis, R.U. Utrecht.Google Scholar
  17. Hoagland, P.D., Pfeffer, P.E. and Valentine, K.M., 1979, Reductive amination of lactose: unusual 13C-n.m.r. spectroscopic properties of N-alkyl(l-deoxy-lactitol-lyl)amines, Carbohydr.Res., 74: 135.CrossRefGoogle Scholar
  18. Hoffman, J., Larm, O. and Schollander, E., 1983, A new method for covalent coupling of heparin and other glycosaminoglycans to substances containing primary aminogroups, Carbohydr.Res., 117: 328.PubMedCrossRefGoogle Scholar
  19. Horton, D. and Phillips, K.D., 1979, The nitrous acid deamination of glycosides and acetates of 2-amino-2-deoxy-D-glucose, Carbohydr.Res., 30: 367.CrossRefGoogle Scholar
  20. Hotchkiss, R.D. and Goebel, W.F., 1937, Chemo-immunological studies on the soluble specific substance of Pneumococcus. III. The structure of aldobionic acid from the type III polysaccharide, J. Biol.Chem., 121: 195.Google Scholar
  21. Hunter, R.L. and Bennett, B., 1984, The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers, J. Immunol., 133: 3167.PubMedGoogle Scholar
  22. Jennings, H.J., 1983, Capsular polysaccharides as human vaccines, Adv. Carbohydr.Chem.Biochem., 41: 155.PubMedCrossRefGoogle Scholar
  23. Kabat, E.A., 1960, The upper limit for the size of the human antidextran combining site, J. Immunol., 84: 82.PubMedGoogle Scholar
  24. Kamerling, J.P., Gerwig, G.J. and Vliegenthart, J.F.G., 1975, Characterization by gas-liquid chromatography-mass spectrometry and proton magnetic resonance spectroscopy of pertrimethylsilyl methyl glycosides obtained in the methanolysis of glycoproteins and glycopeptides, Biochem.J., 151: 491.PubMedGoogle Scholar
  25. Kaufmann, F., Lund, E. and Eddy, B.E., 1960, Proposal for a change in the nomenclature of Diplococcus pneumoniae and a comparison of the Danish and American type designations, Int.Bull.Bacteriol.Nomencl.Taxon., 10: 31.CrossRefGoogle Scholar
  26. Kenne, L. and Lindberg, B., 1983, Bacterial polysaccharides, in: “The Polysaccharides”, Vol. 2, G.O. Aspinall, ed., Academic Press.Google Scholar
  27. Larm, O. and Lindberg, B., 1976, The pneumococcal polysaccharides, a reexamination, Adv.Carbohydr.Chem.Biochem., 33: 295.PubMedCrossRefGoogle Scholar
  28. Lindberg, B., Lnngren, J. and Powell, D.A., 1977, Structural studies on the specific type-14 pneumococcal polysaccharide, Carbohydr.Res., 58: 177.PubMedCrossRefGoogle Scholar
  29. Proctor, R.A., 1984, “Handbook of Endotoxin”, Vol. 1, Chemistry of Endotoxin, E.Th. Rietschel, ed., Elsevier, Amsterdam.Google Scholar
  30. Read, B.D., Demel, R.A., Wiegandt, H. and Van Deenen, L.L.M., 1977, Specific interaction of concanavalin A with glycolipid monolayers, Biochim. Biophys.Acta, 470: 325.PubMedCrossRefGoogle Scholar
  31. Reed, L.J. and Muench, H., 1938, A simple method for estimating fifty percent endpoints, Am.J.Hyg., 27: 493.Google Scholar
  32. Robbins, J.B., 1978, Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future, Immunochemistry, 15: 839.PubMedCrossRefGoogle Scholar
  33. Robbins, J.B., Austrian, R., Lee, C-J., Rastogi, S.C., Schiffman, G., Henrichsen, J., Mkel, P.H., Broome, C.V., Facklam, R.R., Tiesjema, R.H. and Parke, J-C., 1983, Considerations for formulating the second-generation pneumococcal capsular-polysaccharide vaccine with emphasis on the cross-reactive types within groups, J.Infect.Dis., 148: 1136.PubMedCrossRefGoogle Scholar
  34. Scher, I., 1982, The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity, Adv.Immunol., 33: 1.PubMedCrossRefGoogle Scholar
  35. Snippe, H., Van Houte, A.J., Van Dam, J.E.G., de Reuver, M.J., Jansze, M. and Willers, J.M.N., 1983a, Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3, Infect.Immun., 40: 856.PubMedGoogle Scholar
  36. Snippe, H., Van Dam, J.E.G., Van Houte, A.J., Willers, J.M.N., Kamerling, J.P. and Vliegenthart, J.F.G., 1983b, Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3, Infect.Immun., 42: 842.PubMedGoogle Scholar
  37. Snippe, H., Zigterman, J.W.J., Van Dam, J.E.G. and Kemerling, J.P., 1988, Oligosaccharide-haptenated liposomes used as a vaccine to Streptococcus pneumoniae, in: “Liposomes as Drug Carriers”, G. Gregoriadis, ed., J. Wiley & Sons Ltd., Chichester.Google Scholar
  38. Stowell, C.P. and Lee, Y.C., 1980, Neoglycoproteins, the preparation and application of synthetic glycoproteins, Adv.Carbohydr.Chem.Biochem., 37: 225.PubMedCrossRefGoogle Scholar
  39. Svenson, S.B. and Lindberg, A.A., 1978, Immunochemistry of Salmonella O-antigens. Preparation of an octasaccharide-bovine serum albumin immunogen representative of Salmonella serogroup B O-antigen and characterization of the antibody response, J. Immunol., 120: 1750.PubMedGoogle Scholar
  40. Tsai, C.S., 1970, Determination of the degree of polymerization of N-acetyl chitooligoses by chromatographic methods, Anal. Biochem., 36: 114.PubMedCrossRefGoogle Scholar
  41. Uemera, K., Nicolotti, R.A., Six, H.R. and Kinskey, S.C., 1974, Antibody formation in response to liposomal membranes sensitized with N-substituted phosphatidyl ethanolamine derivatives, Biochemistry, 13: 1572.CrossRefGoogle Scholar
  42. Van Houte, A.J., Snippe, H. and Willers, J.M.N., 1979, Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen, Immunology, 37: 505.PubMedGoogle Scholar
  43. Wiegandt, H. and Ziegler, W., 1974, The use of reductaminated sugars for the preparation of oligosaccharide conjugates. I. Synthetic glycolipids containing glycosphingolipid-derived oligosaccharides, Hoppe-Seyler’s Z.Physiol.Chem., 355: 11.PubMedCrossRefGoogle Scholar
  44. Williams, T.J., Plessas, N.R., Goldstein, I.J. and Lnngren, J., 1979, A new class of model glycolipids: synthesis, characterization, and interaction with lectins, Arch.Biochem.Biophys., 195: 145.PubMedCrossRefGoogle Scholar
  45. Wood, C. and Kabat, E.A., 1981a, Immunochemical studies of conjugates of isomaltosyl oligosaccharide to lipid. I. Antigenicity of the glycolipids and the production of specific antibodies in rabbits, J.Exp.Med., 154: 432.PubMedCrossRefGoogle Scholar
  46. Wood, C. and Kabat, E.A., 1981b, Immunochemical studies of conjugates of isomaltosyl oligosaccharide to lipid. II. Specificities and reactivities of the antibodies formed in rabbits to stearylisomaltosyl oligosaccharides, Arch.Biochem.Biophys., 212: 262.PubMedCrossRefGoogle Scholar
  47. Wood, C. and Kabat, E.A., 1981c, Immunochemical studies of conjugates of isomaltosyl oligosaccharide to lipid. III. Fractionation of rabbit antibodies to stearyl-isomaltosyl oligosaccharides and a study of their combining sites by a competitive binding assay, Arch.Biochem. Biophys., 212: 277.PubMedCrossRefGoogle Scholar
  48. Zigterman, J.W.J., Van Dam, J.E.G., Snippe, H., Rotteveel, F.T.M., Jansze, M., Willers, J.M.N., Kamerling, J.P. and Vliegenthart, J.F.G., 1985, Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype II capsular polysaccharide, Infect.Immun., 47: 421.PubMedGoogle Scholar
  49. Zigterman, J.W.J., Snippe, H., Jansze, M. and Willers, J.M.N., 1987, Adjuvant effects of nonionic block polymer surfactants on liposome induced humoral immune response, J. Immunol., 138: 220.PubMedGoogle Scholar
  50. Zigterman, J.W.J., Verheul, A.F.M., Ernste, E.B.H.W., Rombouts, R.F.M., de Reuver, M.J., Jansze, M., Snippe, H. and Willers, J.M.N., 1988, Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniques, J. Immunol.Meth., 106: 101.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • H. Snippe
    • 1
  • A. F. M. Verheul
    • 1
  • J. E. G. van Dam
    • 1
  1. 1.Laboratory of Microbiology Faculty of MedicineUtrecht UniversityUtrechtThe Netherlands

Personalised recommendations